Global Precision Medicine Software Market: Industry Analysis and Forecast (2018-2026) – by Delivery Mode, End User, Application, Region.

Global Precision Medicine Software Market: Industry Analysis and Forecast (2018-2026) – by Delivery Mode, End User, Application, Region.

Market Scenario

Global Precision Medicine Software Market was valued US$ 1.15 Bn in 2017 and is expected to reach US$ 2.8 Bn by 2026, at CAGR of 11.77% during forecast period. Global Precision Medicine Software Market Latest advancements in applications of big data technologies for exact detection of diseases will positively impact the precision medicine market share during the forecast period. Big data analytics are beneficial in chronic disease management. Moreover, software also provides improved clinical workflow. Introduction of such software that usually has improved capacity to store huge amount of genetic data ensuring faster patient recovery will be helpful for the precision medicine industry growth. Also, key industry players focus their efforts on improvement of software that supports drug discovery processes. Software specifically designed to develop precision medicines applied in treatment of chronic diseases as well as genetic diseases ensuring quick patient recovery will expand the precision medicine market size in upcoming years. According to Application, Oncology segment was holding the largest share of Precision Medicine Software Market in 2017. Large share of this segment can be recognized to the growing occurrence of cancer, rising funding in cancer research, capable applications of precision medicine in oncology research, and better investments by government organizations in precision medicine software. North American market was holding the largest share of precision medicine software in 2017. North America in the precision medicine software market can be attributed to factors like growing HCIT investments in the region, presence of regulatory mandates supporting market growth in US, and growing digitalization and favorable funding initiatives by the Canadian government. Industry players implement tactical decisions that supports them with competitive advantage. As, in January 2018, Roche entered into collaboration with Syapse. Sypase is a leading precision medicine company with wide-ranging product portfolio. This collaboration will extend Roche’s precession medicine portfolio which will increase company’s revenue share in the market. Large academic medical centers and professional societies are already promoting from partnerships with IT start-up companies dedicated on precision medicine. Not only does the implementation of these specific platforms help further the advances in precision medicine, but these relationships substitute the competitive environments which will help driving innovation to new heights. Future of the precision medicine marketplace is a bright one. Because of relatively limited adoption rate the opportunities for precision medicine growth and integration in a different array of technologies makes this an area worth watching and one we look forward to exploring further. This report aims at answering several characteristics of global precision medicine market with the help of key factors driving the market, restraints and challenges which can possibly prevent the overall market growth, and the current growth opportunities that are going to figure out the future insight of the market expansion. The report includes an in-depth analysis of the key ecosystem players and key policies & developments taking place in this market. The research study reflects the market share analysis for a complete understanding of global precision medicine market and measures the factors governing the same. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding precision medicine software market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in precision medicine software market.

Scope of Global Precision Medicine Software Market:

Global Precision Medicine Software Market by Delivery Mode:

• On-Premises • Cloud-Based

Global Precision Medicine Software Market by End User:

• Healthcare Providers • Research Centers • Government Institutes • Pharmaceutical • Biotechnology Companies

Global Precision Medicine Software Market by Application:

• Oncology • Immunology • CNS • Respiratory

Global Precision Medicine Software Market by Region:

• North America • Asia Pacific • Europe • Latin America • Middle East & Africa

Key Players Operated in Market Includes:

• Syapse, Inc. • 2bPrecise LLC • Foundation Medicine, Inc. • Fabric Genomics • SOPHiA GENETICS SA • PierianDx, Inc • N-of-One, Inc. • Human Longevity, Inc. • Translational Software, Inc • Sunquest Information Systems Inc • Gene42, Inc. • LifeOmic Health, LLC • NantHealth, Inc • Tempus Labs, Inc. • Flatiron Health, Inc. • IBM Watson Group • Koninklijke Philips N.V. Global Computer Vision in Healthcare Market

Table of Contents

Global Precision Medicine Software Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.2. Secondary data 2.3.3. Secondary Sources 2.3.4. Primary Research 2.3.5. Data from Primary Sources 2.3.6. Breakdown of Primary Sources 3. Executive Summary: Global Precision Medicine Software Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Global Precision Medicine Software Market Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Precision Medicine Software Market Analysis and Forecast 6.1. Global Precision Medicine Software Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Precision Medicine Software Market Analysis and Forecast, By Delivery Mode 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Precision Medicine Software Market Value Share Analysis, By Delivery Mode 7.4. Global Precision Medicine Software Market Size (US$ Bn) Forecast, By Delivery Mode 7.5. Global Precision Medicine Software Market Analysis, By Delivery Mode 7.6. Global Precision Medicine Software Market Attractiveness Analysis, By Delivery Mode 8. Global Precision Medicine Software Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Precision Medicine Software Market Value Share Analysis, By Application 8.4. Global Precision Medicine Software Market Size (US$ Bn) Forecast, By Application 8.5. Global Precision Medicine Software Market Analysis, By Application 8.6. Global Precision Medicine Software Market Attractiveness Analysis, By Application 9. Global Precision Medicine Software Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Precision Medicine Software Market Value Share Analysis, by End User 9.4. Global Precision Medicine Software Market Size (US$ Bn) Forecast, by End User 9.5. Global Precision Medicine Software Market Analysis, by End User 9.6. Global Precision Medicine Software Market Attractiveness Analysis, by End User 10. Global Precision Medicine Software Market Analysis, by Region 10.1. Global Precision Medicine Software Market Value Share Analysis, by Region 10.2. Global Precision Medicine Software Market Size (US$ Bn) Forecast, by Region 10.3. Global Precision Medicine Software Market Attractiveness Analysis, by Region 11. North America Precision Medicine Software Market Analysis 11.1. Key Findings 11.2. North America Precision Medicine Software Market Overview 11.3. North America Precision Medicine Software Market Value Share Analysis, By Delivery Mode 11.4. North America Precision Medicine Software Market Forecast, By Delivery Mode 11.4.1. On-Premises 11.4.2. Cloud-Based 11.5. North America Precision Medicine Software Market Value Share Analysis, By Application 11.6. North America Precision Medicine Software Market Forecast, By Application 11.6.1. Oncology 11.6.2. Immunology 11.6.3. CNS 11.6.4. Respiratory 11.7. North America Precision Medicine Software Market Value Share Analysis, by End User 11.8. North America Precision Medicine Software Market Forecast, by End User 11.8.1. Healthcare Providers 11.8.2. Research Centers 11.8.3. Government Institutes 11.8.4. Pharmaceutical 11.8.5. Biotechnology Companies 11.9. North America Precision Medicine Software Market Value Share Analysis, by Country 11.10. North America Precision Medicine Software Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Precision Medicine Software Market Analysis, by Country 11.12. U.S. Precision Medicine Software Market Forecast, By Delivery Mode 11.12.1. On-Premises 11.12.2. Cloud-Based 11.13. U.S. Precision Medicine Software Market Forecast, By Application 11.13.1. Oncology 11.13.2. Immunology 11.13.3. CNS 11.13.4. Respiratory 11.14. U.S. Precision Medicine Software Market Forecast, by End User 11.14.1. Healthcare Providers 11.14.2. Research Centers 11.14.3. Government Institutes 11.14.4. Pharmaceutical 11.14.5. Biotechnology Companies 11.15. Canada Precision Medicine Software Market Forecast, By Delivery Mode 11.15.1. On-Premises 11.15.2. Cloud-Based 11.16. Canada Precision Medicine Software Market Forecast, By Application 11.16.1. Oncology 11.16.2. Immunology 11.16.3. CNS 11.16.4. Respiratory 11.17. Canada Precision Medicine Software Market Forecast, by End User 11.17.1. Healthcare Providers 11.17.2. Research Centers 11.17.3. Government Institutes 11.17.4. Pharmaceutical 11.17.5. Biotechnology Companies 11.18. North America Precision Medicine Software Market Attractiveness Analysis 11.18.1. By Delivery Mode 11.18.2. By Application 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Precision Medicine Software Market Analysis 12.1. Key Findings 12.2. Europe Precision Medicine Software Market Overview 12.3. Europe Precision Medicine Software Market Value Share Analysis, By Delivery Mode 12.4. Europe Precision Medicine Software Market Forecast, By Delivery Mode 12.4.1. On-Premises 12.4.2. Cloud-Based 12.5. Europe Precision Medicine Software Market Value Share Analysis, By Application 12.6. Europe Precision Medicine Software Market Forecast, By Application 12.6.1. Oncology 12.6.2. Immunology 12.6.3. CNS 12.6.4. Respiratory 12.7. Europe Precision Medicine Software Market Value Share Analysis, by End User 12.8. Europe Precision Medicine Software Market Forecast, by End User 12.8.1. Healthcare Providers 12.8.2. Research Centers 12.8.3. Government Institutes 12.8.4. Pharmaceutical 12.8.5. Biotechnology Companies 12.9. Europe Precision Medicine Software Market Value Share Analysis, by Country 12.10. Europe Precision Medicine Software Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Precision Medicine Software Market Analysis, by Country 12.12. Germany Precision Medicine Software Market Forecast, By Delivery Mode 12.12.1. On-Premises 12.12.2. Cloud-Based 12.13. Germany Precision Medicine Software Market Forecast, By Application 12.13.1. Oncology 12.13.2. Immunology 12.13.3. CNS 12.13.4. Respiratory 12.14. Germany Precision Medicine Software Market Forecast, by End User 12.14.1. Healthcare Providers 12.14.2. Research Centers 12.14.3. Government Institutes 12.14.4. Pharmaceutical 12.14.5. Biotechnology Companies 12.15. U.K. Precision Medicine Software Market Forecast, By Delivery Mode 12.15.1. On-Premises 12.15.2. Cloud-Based 12.16. U.K. Precision Medicine Software Market Forecast, By Application 12.16.1. Oncology 12.16.2. Immunology 12.16.3. CNS 12.16.4. Respiratory 12.17. U.K. Precision Medicine Software Market Forecast, by End User 12.17.1. Healthcare Providers 12.17.2. Research Centers 12.17.3. Government Institutes 12.17.4. Pharmaceutical 12.17.5. Biotechnology Companies 12.18. France Precision Medicine Software Market Forecast, By Delivery Mode 12.18.1. On-Premises 12.18.2. Cloud-Based 12.19. France Precision Medicine Software Market Forecast, By Application 12.19.1. Oncology 12.19.2. Immunology 12.19.3. CNS 12.19.4. Respiratory 12.20. France Precision Medicine Software Market Forecast, by End User 12.20.1. Healthcare Providers 12.20.2. Research Centers 12.20.3. Government Institutes 12.20.4. Pharmaceutical 12.20.5. Biotechnology Companies 12.21. Italy Precision Medicine Software Market Forecast, By Delivery Mode 12.21.1. On-Premises 12.21.2. Cloud-Based 12.22. Italy Precision Medicine Software Market Forecast, By Application 12.22.1. Oncology 12.22.2. Immunology 12.22.3. CNS 12.22.4. Respiratory 12.23. Italy Precision Medicine Software Market Forecast, by End User 12.23.1. Healthcare Providers 12.23.2. Research Centers 12.23.3. Government Institutes 12.23.4. Pharmaceutical 12.23.5. Biotechnology Companies 12.24. Spain Precision Medicine Software Market Forecast, By Delivery Mode 12.24.1. On-Premises 12.24.2. Cloud-Based 12.25. Spain Precision Medicine Software Market Forecast, By Application 12.25.1. Oncology 12.25.2. Immunology 12.25.3. CNS 12.25.4. Respiratory 12.26. Spain Precision Medicine Software Market Forecast, by End User 12.26.1. Healthcare Providers 12.26.2. Research Centers 12.26.3. Government Institutes 12.26.4. Pharmaceutical 12.26.5. Biotechnology Companies 12.27. Rest of Europe Precision Medicine Software Market Forecast, By Delivery Mode 12.27.1. On-Premises 12.27.2. Cloud-Based 12.28. Rest of Europe Precision Medicine Software Market Forecast, By Application 12.28.1. Oncology 12.28.2. Immunology 12.28.3. CNS 12.28.4. Respiratory 12.29. Rest of Europe Precision Medicine Software Market Forecast, by End User 12.29.1. Healthcare Providers 12.29.2. Research Centers 12.29.3. Government Institutes 12.29.4. Pharmaceutical 12.29.5. Biotechnology Companies 12.30. Europe Precision Medicine Software Market Attractiveness Analysis 12.30.1. By Delivery Mode 12.30.2. By Application 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Precision Medicine Software Market Analysis 13.1. Key Findings 13.2. Asia Pacific Precision Medicine Software Market Overview 13.3. Asia Pacific Precision Medicine Software Market Value Share Analysis, By Delivery Mode 13.4. Asia Pacific Precision Medicine Software Market Forecast, By Delivery Mode 13.4.1. On-Premises 13.4.2. Cloud-Based 13.5. Asia Pacific Precision Medicine Software Market Value Share Analysis, By Application 13.6. Asia Pacific Precision Medicine Software Market Forecast, By Application 13.6.1. Oncology 13.6.2. Immunology 13.6.3. CNS 13.6.4. Respiratory 13.7. Asia Pacific Precision Medicine Software Market Value Share Analysis, by End User 13.8. Asia Pacific Precision Medicine Software Market Forecast, by End User 13.8.1. Healthcare Providers 13.8.2. Research Centers 13.8.3. Government Institutes 13.8.4. Pharmaceutical 13.8.5. Biotechnology Companies 13.9. Asia Pacific Precision Medicine Software Market Value Share Analysis, by Country 13.10. Asia Pacific Precision Medicine Software Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Precision Medicine Software Market Analysis, by Country 13.12. China Precision Medicine Software Market Forecast, By Delivery Mode 13.12.1. On-Premises 13.12.2. Cloud-Based 13.13. China Precision Medicine Software Market Forecast, By Application 13.13.1. Oncology 13.13.2. Immunology 13.13.3. CNS 13.13.4. Respiratory 13.14. China Precision Medicine Software Market Forecast, by End User 13.14.1. Healthcare Providers 13.14.2. Research Centers 13.14.3. Government Institutes 13.14.4. Pharmaceutical 13.14.5. Biotechnology Companies 13.15. India Precision Medicine Software Market Forecast, By Delivery Mode 13.15.1. On-Premises 13.15.2. Cloud-Based 13.16. India Precision Medicine Software Market Forecast, By Application 13.16.1. Oncology 13.16.2. Immunology 13.16.3. CNS 13.16.4. Respiratory 13.17. India Precision Medicine Software Market Forecast, by End User 13.17.1. Healthcare Providers 13.17.2. Research Centers 13.17.3. Government Institutes 13.17.4. Pharmaceutical 13.17.5. Biotechnology Companies 13.18. Japan Precision Medicine Software Market Forecast, By Delivery Mode 13.18.1. On-Premises 13.18.2. Cloud-Based 13.19. Japan Precision Medicine Software Market Forecast, By Application 13.19.1. Oncology 13.19.2. Immunology 13.19.3. CNS 13.19.4. Respiratory 13.20. Japan Precision Medicine Software Market Forecast, by End User 13.20.1. Healthcare Providers 13.20.2. Research Centers 13.20.3. Government Institutes 13.20.4. Pharmaceutical 13.20.5. Biotechnology Companies 13.21. ASEAN Precision Medicine Software Market Forecast, By Delivery Mode 13.21.1. On-Premises 13.21.2. Cloud-Based 13.22. ASEAN Precision Medicine Software Market Forecast, By Application 13.22.1. Oncology 13.22.2. Immunology 13.22.3. CNS 13.22.4. Respiratory 13.23. ASEAN Precision Medicine Software Market Forecast, by End User 13.23.1. Healthcare Providers 13.23.2. Research Centers 13.23.3. Government Institutes 13.23.4. Pharmaceutical 13.23.5. Biotechnology Companies 13.24. Rest of Asia Pacific Precision Medicine Software Market Forecast, By Delivery Mode 13.24.1. On-Premises 13.24.2. Cloud-Based 13.25. Rest of Asia Pacific Precision Medicine Software Market Forecast, By Application 13.25.1. Oncology 13.25.2. Immunology 13.25.3. CNS 13.25.4. Respiratory 13.26. Rest of Asia Pacific Precision Medicine Software Market Forecast, by End User 13.26.1. Healthcare Providers 13.26.2. Research Centers 13.26.3. Government Institutes 13.26.4. Pharmaceutical 13.26.5. Biotechnology Companies 13.27. Asia Pacific Precision Medicine Software Market Attractiveness Analysis 13.27.1. By Delivery Mode 13.27.2. By Application 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Precision Medicine Software Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Precision Medicine Software Market Overview 14.3. Middle East & Africa Precision Medicine Software Market Value Share Analysis, By Delivery Mode 14.4. Middle East & Africa Precision Medicine Software Market Forecast, By Delivery Mode 14.4.1. On-Premises 14.4.2. Cloud-Based 14.5. Middle East & Africa Precision Medicine Software Market Value Share Analysis, By Application 14.6. Middle East & Africa Precision Medicine Software Market Forecast, By Application 14.6.1. Oncology 14.6.2. Immunology 14.6.3. CNS 14.6.4. Respiratory 14.7. Middle East & Africa Precision Medicine Software Market Value Share Analysis, by End User 14.8. Middle East & Africa Precision Medicine Software Market Forecast, by End User 14.8.1. Healthcare Providers 14.8.2. Research Centers 14.8.3. Government Institutes 14.8.4. Pharmaceutical 14.8.5. Biotechnology Companies 14.9. Middle East & Africa Precision Medicine Software Market Value Share Analysis, by Country 14.10. Middle East & Africa Precision Medicine Software Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Precision Medicine Software Market Analysis, by Country 14.12. GCC Precision Medicine Software Market Forecast, By Delivery Mode 14.12.1. On-Premises 14.12.2. Cloud-Based 14.13. GCC Precision Medicine Software Market Forecast, By Application 14.13.1. Oncology 14.13.2. Immunology 14.13.3. CNS 14.13.4. Respiratory 14.14. GCC Precision Medicine Software Market Forecast, by End User 14.14.1. Healthcare Providers 14.14.2. Research Centers 14.14.3. Government Institutes 14.14.4. Pharmaceutical 14.14.5. Biotechnology Companies 14.15. South Africa Precision Medicine Software Market Forecast, By Delivery Mode 14.15.1. On-Premises 14.15.2. Cloud-Based 14.16. South Africa Precision Medicine Software Market Forecast, By Application 14.16.1. Oncology 14.16.2. Immunology 14.16.3. CNS 14.16.4. Respiratory 14.17. South Africa Precision Medicine Software Market Forecast, by End User 14.17.1. Healthcare Providers 14.17.2. Research Centers 14.17.3. Government Institutes 14.17.4. Pharmaceutical 14.17.5. Biotechnology Companies 14.18. Rest of Middle East & Africa Precision Medicine Software Market Forecast, By Delivery Mode 14.18.1. On-Premises 14.18.2. Cloud-Based 14.19. Rest of Middle East & Africa Precision Medicine Software Market Forecast, By Application 14.19.1. Oncology 14.19.2. Immunology 14.19.3. CNS 14.19.4. Respiratory 14.20. Rest of Middle East & Africa Precision Medicine Software Market Forecast, by End User 14.20.1. Healthcare Providers 14.20.2. Research Centers 14.20.3. Government Institutes 14.20.4. Pharmaceutical 14.20.5. Biotechnology Companies 14.21. Middle East & Africa Precision Medicine Software Market Attractiveness Analysis 14.21.1. By Delivery Mode 14.21.2. By Application 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Precision Medicine Software Market Analysis 15.1. Key Findings 15.2. South America Precision Medicine Software Market Overview 15.3. South America Precision Medicine Software Market Value Share Analysis, By Delivery Mode 15.4. South America Precision Medicine Software Market Forecast, By Delivery Mode 15.4.1. On-Premises 15.4.2. Cloud-Based 15.5. South America Precision Medicine Software Market Value Share Analysis, By Application 15.6. South America Precision Medicine Software Market Forecast, By Application 15.6.1. Oncology 15.6.2. Immunology 15.6.3. CNS 15.6.4. Respiratory 15.7. South America Precision Medicine Software Market Value Share Analysis, by End User 15.8. South America Precision Medicine Software Market Forecast, by End User 15.8.1. Healthcare Providers 15.8.2. Research Centers 15.8.3. Government Institutes 15.8.4. Pharmaceutical 15.8.5. Biotechnology Companies 15.9. South America Precision Medicine Software Market Value Share Analysis, by Country 15.10. South America Precision Medicine Software Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Precision Medicine Software Market Analysis, by Country 15.12. Brazil Precision Medicine Software Market Forecast, By Delivery Mode 15.12.1. On-Premises 15.12.2. Cloud-Based 15.13. Brazil Precision Medicine Software Market Forecast, By Application 15.13.1. Oncology 15.13.2. Immunology 15.13.3. CNS 15.13.4. Respiratory 15.14. Brazil Precision Medicine Software Market Forecast, by End User 15.14.1. Healthcare Providers 15.14.2. Research Centers 15.14.3. Government Institutes 15.14.4. Pharmaceutical 15.14.5. Biotechnology Companies 15.15. Mexico Precision Medicine Software Market Forecast, By Delivery Mode 15.15.1. On-Premises 15.15.2. Cloud-Based 15.16. Mexico Precision Medicine Software Market Forecast, By Application 15.16.1. Oncology 15.16.2. Immunology 15.16.3. CNS 15.16.4. Respiratory 15.17. Mexico Precision Medicine Software Market Forecast, by End User 15.17.1. Healthcare Providers 15.17.2. Research Centers 15.17.3. Government Institutes 15.17.4. Pharmaceutical 15.17.5. Biotechnology Companies 15.18. Rest of South America Precision Medicine Software Market Forecast, By Delivery Mode 15.18.1. On-Premises 15.18.2. Cloud-Based 15.19. Rest of South America Precision Medicine Software Market Forecast, By Application 15.19.1. Oncology 15.19.2. Immunology 15.19.3. CNS 15.19.4. Respiratory 15.20. Rest of South America Precision Medicine Software Market Forecast, by End User 15.20.1. Healthcare Providers 15.20.2. Research Centers 15.20.3. Government Institutes 15.20.4. Pharmaceutical 15.20.5. Biotechnology Companies 15.21. South America Precision Medicine Software Market Attractiveness Analysis 15.21.1. By Delivery Mode 15.21.2. By Application 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Syapse, Inc 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. 2bPrecise LLC 16.3.3. Foundation Medicine, Inc. 16.3.4. Fabric Genomics 16.3.5. SOPHiA GENETICS SA 16.3.6. PierianDx, Inc 16.3.7. N-of-One, Inc. 16.3.8. Human Longevity, Inc. 16.3.9. Translational Software, Inc 16.3.10. Sunquest Information Systems Inc 16.3.11. Gene42, Inc. 16.3.12. LifeOmic Health, LLC 16.3.13. NantHealth, Inc 16.3.14. Tempus Labs, Inc. 16.3.15. Flatiron Health, Inc. 16.3.16. IBM Watson Group 16.3.17. Koninklijke Philips N.V. 17. Primary Key Insights

About This Report

Report ID28165
Published DateMarch 2019
Contact Us
Call Now